Robuta

https://pmc.ncbi.nlm.nih.gov/articles/PMC11592889/ Does Incretin Agonism Have Sustainable Efficacy? - PMC Recent clinical trials using synthetic incretin hormones, glucagon-like peptide 1 (GLP-1), and glucose-dependent insulinotropic polypeptide (GIP) receptor... sustainableefficacypmc https://pubchem.ncbi.nlm.nih.gov/bioassay/1804950 AID 1804950 - In Vitro Functional Activity (Agonism) on Human S1P5 Receptors from US Patent... BioAssay record AID 1804950 submitted by BindingDB: In Vitro Functional Activity (Agonism) on Human S1P5 Receptors from US Patent US10807991: https://pmc.ncbi.nlm.nih.gov/articles/PMC2948287/ Biased agonism - PMC Seven-transmembrane receptors are commonly coupled to multiple signaling pathways in cells. The simple model describing agonists for these receptors as... biasedpmc https://experts.mcmaster.ca/scholarly-works/210990 Combined mTOR inhibition and OX40 agonism enhances... Learn about the scholarly work entitled Combined mTOR inhibition and OX40 agonism enhances... combinedmtorinhibitionenhances https://pmc.ncbi.nlm.nih.gov/articles/PMC12273586/ How THC works: Explaining ligand affinity for, and partial agonism of, cannabinoid receptor 1 - PMC Interaction with cannabinoid receptor 1 (CB1) partially determines the bioactivity of the phytocannabinoids. Consequently, there has also been significant... https://research.monash.edu/en/publications/broad-spectrum-neuroprotection-against-traumatic-brain-injury-by-/ Broad-spectrum neuroprotection against traumatic brain injury by agonism of peroxisome... traumatic brain injurybroad spectrumneuroprotection https://www.frontiersin.org/journals/systems-neuroscience/articles/10.3389/fnsys.2021.698240/full Frontiers | Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Results in Sustained... Background: myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex multi-symptom disease with widespread evidence of disrupted systems. The... https://researchdiscovery.drexel.edu/esploro/outputs/doctoral/D3-receptor-agonism-attenuates-deficits-observed/991014632191604721 D3 receptor agonism attenuates deficits observed in rodents with 6-OHDA-induced medial forebrain... Parkinson's Disease (PD) is a neurodegenerative disorder associated with the progressive loss of dopaminergic neurons in the substantia nigra. This pathology... https://pmc.ncbi.nlm.nih.gov/articles/PMC10705578/ Physiology of the Weight Loss Plateau after Calorie Restriction, GLP-1 Receptor Agonism, and... To investigate why different weight loss interventions result in varying durations of weight loss prior to approaching plateaus. A validated mathematical model... https://events.diabetes.org/p/s/gip-agonism-vs-antagonism-3953 GIP Agonism vs. Antagonism - American Diabetes Association american diabetesgipvsantagonismassociation https://boris-portal.unibe.ch/entities/publication/ee866270-4239-45c4-9b18-25a97d2b31af Correction: GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body... gip receptorcorrectionimproves https://pubmed.ncbi.nlm.nih.gov/40301583/ GIPR agonism and antagonism decrease body weight and food intake via different mechanisms in male... Agonists and antagonists of the glucose-dependent insulinotropic polypeptide receptor (GIPR) enhance body weight loss induced by glucagon-like peptide-1... https://pubmed.ncbi.nlm.nih.gov/16011657/ Estrogenic agonism and antagonism of the soy isoflavone genistein in uterus, bone and lymphopoiesis... The isoflavone genistein (Gen) is a naturally occurring phytoestrogen found in high concentrations in soy. The biological effects of Gen have been extensively... https://www.research.va.gov/about/funded_research/proj-details-FY2023.cfm?pid=582930 I01BX001786-06A1 - PPARgamma agonism in lung immune response lungimmuneresponse https://www.mdpi.com/2073-4409/9/1/37 Anti-NASH Drug Development Hitches a Lift on PPAR Agonism Non-alcoholic fatty liver disease (NAFLD) affects one-third of the population worldwide, of which a substantial number of patients suffer from non-alcoholic... drug developmentantinashhitcheslift https://www.southampton.ac.uk/research/projects/developing-immunostimulatory-antibodies-to-deliver-agonism-without-toxicity Developing immunostimulatory antibodies to deliver agonism without toxicity | University of... Developing immunostimulatory antibodies to deliver agonism without toxicity. developingantibodiesdeliverwithouttoxicity https://researchconnect.buffalo.edu/en/publications/targeting-pro-dopaminergic-agonism-to-attenuate-and-depression-in/ Targeting pro-dopaminergic agonism to attenuate and depression in patient's displaying... https://events.diabetes.org/p/s/what-does-glucagon-receptor-agonism-add-to-the-effects-of-gip-and-glp-1-receptor-agonism-5584 What Does Glucagon Receptor Agonism Add to the Effects of GIP and GLP-1 Receptor Agonism? -... https://research.monash.edu/en/publications/new-paradigms-in-adenosine-receptor-pharmacology-allostery-oligom/ New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism -... adenosine receptornewparadigms